Drugs / BAY1097761
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04417036 | Jul 2020 → Dec 2022 | acute respiratory distress syndrome | Bayer | Terminated | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY1097761 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04417036 ↗ |